Research report covers the Stroke Post Processing Software Market share and Growth, 2020-2027

 Upcoming Stroke Post Processing Software Market trends projected to list a CAGR of 6.48% to influence income generation of USD 1,294.24 Million by 2024. A stroke can be defined as the absence of blood flow to brain tissues, resulting in vascular assembly within the brain. Furthermore, increasing awareness regarding the benefit of stroke post-processing software in individuals and healthcare professionals would create more demand for these products, boosting the global stroke post-processing software market’s growth.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/8208

Market Highlights

The Global Stroke Post Processing Software Market is expected to register a CAGR of 6.48% during the forecast period, with a market value of USD 898.87 Million in 2018. A stroke can be defined as the lack of blood flow to brain tissues and can occur in any vascular structure within the brain.

The collaborations between start-up companies & big market players in the industry, increasing burden of ischemic strokes, and growth in the geriatric population are likely to contribute to the growth of the market during the assessment period. For instance, in January 2019, iSchemaView and NeuroLogica, a subsidiary of Samsung Electronics Co., Ltd and leader in medical imaging technology, collaborated to integrate iSchemaView’s RAPID cerebrovascular imaging platform with NeuroLogica’s portable CereTom CT scanners for use in MSUs and ICUs across the globe. However, stringent regulatory policies is likely to restrain the market growth during the forecast period.

Segment Analysis

The global stroke post processing software market, by installation, has been segmented into the desktop, mobile phones, and tablets. By modality, the market has been segregated into CT Scan and MRI. Based on type, the market has been divided into the ischemic stroke, hemorrhagic stroke, and others. On the basis of the end user, the global stroke post processing software market has been classified as hospitals & clinics, specialty centers, and others. The hospitals and clinics segment accounted for a value of USD 479.89 million in 2018.

Regional Analysis

Geographically, the global stroke post processing software market has been categorized as Europe, the Americas, Asia-Pacific, and the Middle East & Africa. Europe is expected to hold the largest share of the global stroke post processing software market. This is due to the presence of a well-developed healthcare infrastructure. Moreover, European companies offering stroke post processing software are getting involved in collaborations, mergers, and product launches to gain substantial market share, which in turn is positively affecting market growth. Americas showed a considerable amount of growth in the market due to the presence of an established healthcare system and two major stroke post processing software companies in the US, namely Viz.ai, Inc. and iSchemaView, Inc. Asia-Pacific is estimated to be the fastest-growing region in the global market due to the presence of some rapidly developing economies. Also, the availability of scientific expertise in Asia-Pacific is likely to contribute to market growth. The large patient pool for heart diseases in Asia-Pacific creates additional opportunities for market growth. Japan held a share of 28.5% in the Asia-Pacific stroke post processing software market in 2018. Also, the market in the Middle East & Africa is expected to demonstrate slow growth.

Market Players

Market Research Future (MRFR) recognizes the following companies as key players in the global stroke post processing software market that include Brainomix (UK), Viz.ai, Inc. (US), iSchemaView, Inc. (US), General Electric Company (US), Koninklijke Philips NV (Netherlands), and Siemens (Germany).

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/stroke-post-processing-software-market-8208

About US:

 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Articaine Hydrochloride Market to Witness Widespread Expansion During 2020-2027

 The Global Articaine Hydrochloride Market is expected to register 8.5% CAGR and is anticipated to reach USD 1,889.0 million by 2025. 

Articaine is a form of a local amide anesthetic that is most commonly used in dentistry. The articaine is marketed as a colorless liquid in vials/cartridges (2ml in each vial/cartridge). It is available in two variants, i.e., Articaine-100 & Articaine-200. Articaine-200 is more potent than Articaine-100. The dosage can be based on the type and extent of surgical procedure, depth of anesthesia, degree of muscular relaxation, and condition of the patient. For pediatric patients, dosage based on their age, weight, the physical condition of the patient, and the extent of the surgical procedure.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2542

The articaine hydrochloride industry is growing rapidly. Articaine, with its greater ability to diffuse through tissues, become a very widely used local anesthetic in the European and Canadian markets.

Market Dynamics

Articaine hydrochloride is the most popular local anesthetic for dentistry. For example, in Germany, around 97% of the anesthetic used by dentists is articaine hydrochloride. The growth of the market is likely to be driven by increasing incidences of dental caries and other periodontal diseases, advancement in dental anesthesia delivery system device, increasing the use of articaine for dental surgery, innovative nature of the dental anesthetics industry, and vigorous research and development efforts. Periodontal disease is one of the major dental diseases that influence human populations worldwide at high prevalence rates. Periodontal diseases are more prevalent in Asia-Pacific. Lack of the most basic oral health education and limited availability of simple interventions like pain relief and emergency care for acute infection and trauma to the vast majority of the population, especially in the rural areas are major reasons for the high incidences of periodontal diseases in the region. According to the FDI World Dental Federation, more than 80% of people in Asia-Pacific, including countries such as India, Bangladesh, Nepal, Malaysia, and Indonesia, suffer from dental decay. Furthermore, 40–59% of the population in China and Australia suffer from dental caries.

Some of the popular local anesthesia other than articaine are prilocaine, lidocaine, mepivacaine, and bupivacaine. The availability and usage of alternative products are likely to thwart the growth of the articaine hydrochloride market during the forecast period.

Segmentation

The global articaine hydrochloride market has been segmented into application and end user.  Based on the articaine hydrochloride market application has been segmented into infiltration, nerve block, and others. Based on end-user, the global market has been segmented into dental clinics, hospitals, and academics & research institutes. The dental clinics segment accounted for a market value of USD 798.5 million in 2018.

Key Players

The prominent players in the global articaine hydrochloride market are 3M (US), Anhui BBCA Pharmaceutical Co., Ltd. (China), Dentsply Sirona (US), Inibsa Dental S.L.U (Spain), Jinan Chenghui Shuangda Chemical Co., Ltd. (China), Jinan Ruixing Pharmaceutical Technology Co., Ltd (China), Manus Aktteva Biopharma LLP (India), Pfizer Inc. (US), Pierrel S.p.A (Italy), Sanofi (France), Septodont (France), Siegfried AG (Switzerland), and Sigma Aldrich (US).

Some of the key strategies followed by the players operating in the global articaine hydrochloride market were innovation, product development, acquisition, and expansion.

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/articaine-hydrochloride-market-2542

About US:

 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Sterilization Technology Market to Witness Widespread Expansion During 2020-2027

 Sterilization refers to a process that eliminates, or kills all pathogens using various technologies and methods that are applied for sterilization of equipment and medical devices in healthcare institutes. There is an increase in demand for sterilization technologies across the globe. Patient safety and the prevention of hospital-acquired infections being a significant concern have led to the rise in the demand for sterilization technologies in healthcare. The global sterilization technology market size is expected to register a CAGR of 8.20% and is anticipated to reach USD 8,142.61 million by 2023. 

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1312

Market Dynamics

Sterilization is the process that destroys or eliminates all forms of microbial life and is carried out in health-care facilities by physical or chemical methods. Sterilization technology includes processes such as gamma radiation, electron beam radiation, filtration, ionizing radiation, and thermal sterilization methods to destroy all microorganisms on the surface of an article or in a fluid to prevent disease transmission.

The sterilization technology market is driven by the increasing occurrences of hospital-acquired infections, increasing number of surgical procedures, growth in the pharmaceutical and biotechnology industries, and rising technological advancements in sterilization equipment. However, the stringent regulatory framework is expected to hamper the growth of the market during the forecast period.

Hospital-acquired infections are healthcare-associated infections that occur in patients under medical care who are not present or incubating at the time of admission. According to the World Health Organization, hundreds of millions of patients are affected by healthcare-associated infections (HAI) worldwide each year, leading to significant mortality and financial losses for health systems. Further, as per the European Centre for Disease Prevention and Control, approximately 30% of patients in Intensive Care Units (ICUs) are affected by at least one episode of healthcare-associated infection. Additionally, according to the World Health Organization (WHO), the prevalence of healthcare-associated infections varies between 5.7% and 19.1% in low- and middle-income countries. These increasing occurrences of HAIs have been leading to substantial financial losses for the overall healthcare system. This vast population affected with HAI are due to insufficient applications of standard and isolation precautions, whereas disinfection and sterilization ensure that medical and surgical instruments do not transmit infectious pathogens to patients. This considerable population affected with HAI and inversely rising need for sterilization are paving the way for a growth curve in the sterilization technology market

Segmentation

The global sterilization technology market has been segmented into type of sterilization, process, and end-user.

The global sterilization technology market based on the type of sterilization has been segmented into ethylene oxide, ionizing radiation (gamma radiation, electron beam radiation, and X-ray radiation), filtration, thermal sterilization, and others. Ethylene oxide takes accounted for 48.1% of market share, due to its high penetration, the strength of the radiation dose, and its exposure time. However, ionizing radiation is also likely to take up equal share due to significant health concerns related to the use of ethylene oxide.

The global sterilization technology, by the process, has been segregated into the chemical process (hydrogen peroxide, ozone, and chlorine dioxide), physicochemical (plasma and steam), synergetic processes (psoralens & UVA and low-temperature steam & formaldehyde), and physical processes (microwaves and pulsed light system). These processes use different compounds for sterilization of articles or surfaces.

Based on the end user, the market has been divided into the pharmaceutical industry, hospitals & clinics, and medical device manufacturers. Pharmaceutical industry dominates the global market for sterilization technology. It accounted for the largest market share of 38.4% and was valued at USD 1948.10 million in the year 2017 and is expected to reach USD 3163.60 million by 2023. Effective sterilization processes are vital within the pharmaceutical industries, and the safety of process units and final products depends on the highest quality of hygienic practice, as well as strict controls and regulatory compliance.

Key Players

The prominent players in the global sterilization technology market are Advanced Sterilization Products Services Inc., Atec Pharmatechnik GmbH, Sterile Technologies Inc., Steris PLC, 3M Company, Feldmeier Equipment Co., Donaldson Co. Inc., and Beta Star Life Science Equipment Inc.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/sterilization-technologies-market-1312

About US:

 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Nerve Stimulators Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 The Global Nerve Stimulators Market is expected to register a CAGR of 9.7% to reach USD 10,978.5 million till 2023. Nerve stimulation is a therapy that uses low-voltage electrical current for pain relief. The nerve stimulator used in nerve stimulation therapy is a bit like a heart pacemaker. In peripheral nerve and spinal cord stimulation, small pulse generator delivers electrical pulses to the nerves or the spinal cord. Nerve stimulator therapy has also proved as an efficient approach to get relief from neurological disorders. Among neurological disorders, nerve stimulation therapy is most commonly used for epilepsy and depression.

Rising incidence of chronic health problems, technological improvements, increasing geriatric population, and improved reimbursement policies in developed countries are expected to enhance the market growth. However, the lack of skilled or trained physicians and high cost of nerve stimulation therapy are projected to curb the growth of the market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/5258

Market Dynamics

Nerve stimulators have been gaining significance in recent years, owing to the increasing incidence of chronic health problems and increasing geriatric population. For instance, according to a study published in Pain Research and Management in 2017, the prevalence of chronic pain among Brazilian population was 39%, 31.7% in the French population, 48% in the UK, and 50% in the UK. Moreover, According to WHO, it is estimated that the world’s population aged 60 years and older will nearly double from 12% to 22% by 2050.

Segmentation

The global nerve stimulators market, by type, has been segmented into deep brain stimulator, a vagus nerve stimulator, and spinal cord stimulator. Based on applications, the nerve stimulators market has been classified as chronic pain, depression, dystonia, epilepsy, Parkinson’s disease, and others. Based on end user, the market has been classified as ambulatory surgical centers, hospital & clinics, trauma centers, and others.

Regional Analysis

The global nerve stimulators market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to hold the largest nerve stimulators market share of the global nerve stimulators market. North America is expected to dominate the market, mainly due to the increasing geriatric population. According to a study published in the Drug and Alcohol Dependence journal in 2017, more than 100 million adult Americans are living with chronic pain. Chronic low back pain and headaches are the most commonly diagnosed conditions. It is also stated that conditions are more prevalent in women than men, i.e., 34.3% in women, and 26.7% in men in the US.

Europe is expected to account for the second-largest market share during the forecast period. The factors responsible for market growth in this region are the presence of huge geriatric population and high healthcare spending.

Asia-Pacific is estimated to be the fastest-growing region in the global market due to the presence of a vast neurological disorder’s patient population, presence of tremendous opportunities for the development of the market drive the growth of the nerve stimulators market in Asia-Pacific. According to a study published in Neurology India journal in 2014, it is found that out of a total population of India, around 30 million people were suffering from neurological disorders in India.

The nerve stimulators market in the Middle East & Africa is expected to grow due to the presence of a well-developed healthcare sector.

Key Players

The prominent players in the global nerve stimulators market are Boston Scientific Corporation, Medtronic, Cochlear Ltd, St Jude Medical, Inc., Cyberonics, Inc., Aleva Neurotherapeutics SA, and NeuroPace, Inc.

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/nerve-stimulator-market-5258

About US:

 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Egg Allergy Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 The Global Egg Allergy Market outlook by MRFR expected to register a CAGR of 7.10%and is anticipated to reach USD 2304.3 Million by 2023. Egg allergies are the most common food allergies. Symptoms of egg allergy can occur immediately or within a few minutes or a few hours. Egg allergy can affect infants as well as adults. The adverse effects of egg allergy can vary from hives or rashes to a severe allergic reaction known as anaphylaxis. Egg allergy happens when there is an overreaction to eggs by the immune system. The immune system identifies egg proteins as harmful and triggers an allergic reaction.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4734

The increasing prevalence of egg allergy and improved allergy diagnosis are the major drivers propelling market growth. However, the lack of awareness in developing countries and high cost constrain the growth of the market.

Market Dynamics

The continued growth in several egg allergy patients is responsible for the increasing demand for required diagnostic tests and medication such as epinephrine autoinjectors, and ultimately, it is propelling the growth of the market. For instance, according to the report published by, McGill University in 2016, egg allergy is common in infants and young children and affects 1 to 2% of the preschool children. Additionally, improved allergy diagnosis is likely to support market growth. On the other hand, the lack of awareness in developing countries and high cost is anticipated to hamper the market growth.

Segmentation

The global egg allergy market has been segmented into age type, diagnosis & treatment, and end user. By age type, the market has been segmented into children and adults. The global egg allergy market has two primary sides—diagnosis & treatment. The global egg allergy market, by diagnosis, has been segmented into skin test, blood test, food challenge, and others. The global egg allergy market, by treatment, has been segmented into medication and oral immunotherapy. By end-user, the market has been segmented into hospitals and clinics, diagnostic centers, research institutes, and others. The hospitals and clinics segment accounted for a market value of USD 729.2 million in 2017.  

Key Players

The prominent players in the global egg allergy market are Sanofi SA (France), Genentech, Inc. (the US), Quest Diagnostics (US), ImmuneTech (US), HYCOR Biomedical (US), Kaleo, Inc. (the US), Alletess Medical Laboratory (US), Creative Diagnostics (US), Imutest Ltd (UK), Mylan NV (US), and Impax Laboratories (US).

Some of the key strategies followed by the players operating in the global egg allergy market were innovation, product development, acquisition, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/egg-allergy-market-4734

 

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

New research report offers detailed research on developments in Tissue Microarray Market 2027

 The Global Tissue Microarray Market is expected to register a CAGR of 10.54% and is anticipated to reach USD 10,914.54 million by 2023. Tissue microarrays are paraffin blocks that are created by separating cylindrical tissue cores from different paraffin donor blocks and re-embedding these into a microarray at defined array coordinates. With the help of tissue microarray, up to at least 1000 tissue samples can be arrayed into a single paraffin piece. It allows simultaneous analysis of molecules present in DNA, mRNA, and protein levels under identical, standardized conditions on a single glass slide. This adaptable strategy, in which data analysis is automated, facilitates retrospective and prospective human tissue studies.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1213

The increasing application in drug discovery, increasing prevalence of cancer, growing advancements in biotechnology and pharmaceutical companies, and rising demand for cost-effective and accurate diagnostic methods are the major drivers propelling market growth. However, tissue microarray may not be fruitful for heterogeneous cancers, which is likely to constrain the growth of the market.

Key Players

The prominent players in the global tissue microarray market trends are Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, QIAGEN, Takara Bio, Perkin Elmer, and Merck Sharp & Dohme Corp.

Market Dynamics

The prevalence of cancer is one of the crucial factors that drive the growth of the tissue microarray market. According to the American Cancer Society, in 2017, nearly 13% of all cancers diagnosed in adults aged 20. It further stated that rates of liver cancer, thyroid cancer, and melanoma are increasing from last few years. According to US Breast Cancer Statistics, about 1 in 8 US women (about 12%) will develop invasive breast cancer throughout their lifetime. In 2017, an estimated 252,710 new cases of invasive breast cancer were expected to be diagnosed in women in the US, along with 63,410 new cases of non-invasive (in-situ) breast cancer.

Moreover, increasing advancements in biotechnology and pharmaceutical companies and growing demand for cost-effective and accurate diagnostic methods have fueled the growth of the market. On the other hand, tissue microarray is that it may not be fruitful for heterogeneous cancers anticipated to hamper the market growth.

Segmentation

The global tissue microarray market has been divided into the procedure, technology, application, and end user. By procedure, the market has been segregated into immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array. Based on technology, the market has been segmented into DNA microarray, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, and western blotting. Based on the application, the market has been bifurcated into oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, comparative genomic hybridization, and sequencing bioinformatics. By end-user, the market has been classified as pharmaceutical and biotechnological companies and research organization. The research organization segment accounted for a market value of USD 1876.02 million in 2016.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/tissue-microarray-market-1213

 

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Automated Hospital Beds Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Upcoming Global Automated Hospital Beds Market trends expected to register a CAGR of 5.97% and is anticipated to reach USD 2,553.4 million by 2023. 

Automated hospital beds are specially designed for hospitalized patients in need of some form of health care services. These hospitals beds have special features both for the comfort and well-being of the patient and for the convenience of health care workers. Most common features of automated hospital beds are automated adjustable height for the entire bed including the head and the feet, adjustable side rails, and electronic buttons to operate both the bed and other nearby electronic devices.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4250

The increase in the number of various acute and chronic disorders, rising geriatric population, increased number of obese people, continuous development in the designs of the hospital beds for the betterment and more comfort of the patients, and rising healthcare expenditure are the major drivers propelling market growth. However, the high cost of automated hospital beds and expensive maintenance of automated hospital beds are hampering the growth of the market.

Market Dynamics

The rise in the incidence rates of chronic disorders is expected to drive the growth of the market. According to the American Autoimmune Related Diseases Association, in 2017, approximately 50 million Americans were suffering from autoimmune diseases, and more than USD 591 million was spent on research and development of autoimmune disorders. Moreover, the increasing geriatric population, increased number of obese people are also likely to support market growth. On the other hand, the high cost of automated beds and the expensive maintenance of hospital beds is anticipated to hamper the market growth.

Segmentation

The global automated hospital beds market has been segmented into type, technology, type of treatment, usage and end user. By type, the market has been segmented into semi-automatic hospital beds and fully automatic hospital beds. Technology segment has been divided into basic automated hospital beds and smart, automated hospital beds. Based on the type of treatment, the market has been segmented into critical care, acute care, and long-term care. Based on usage, the market has been segmented into general-purpose, intensive care, delivery/birthing, bariatric, pediatric, psychiatric care, pressure relief, and others. By end-user, the market has been segmented hospitals & clinics reproductive care centers, dentistry, home care, and others. The hospitals & clinics segment accounted for a market value of USD  627.4 million in 2016.

Key Players

The prominent players in the global automated hospital beds market are ArjoHuntleigh, Gendron Inc, Hill-Rom Holdings, Invacare Corporation, Linet spol. SRO, Medline Industries, Inc., Stryker Corporation, Paramount Bed Holdings Co., Ltd., and Others.

Regional Analysis

The global automated hospital beds market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The European region is estimated to dominate the global automated hospital beds market during the forecast period. This is attributed to the continuous innovation and new product development, moreover, to rise in prevalence of life-threatening diseases, increasing healthcare expenditure and increasing technological advances play a vital role in the growth of the regional market. Furthermore, in an automated hospital beds market, Europe accounted for a market share of 36.0% in 2016. The North America market for automated hospital beds is expected to be the second-largest during the forecast period. Factors such as stable economic conditions and continuously developing technologies and significant investments by hospitals to upgrade their equipment’s including beds is expected to boost the growth of the market in this region. For instance, According to WHO, the North American population is projected to grow by 42% from 2000 to 2050, and so it is imperative that the supply of health care maintains pace with the increased demand

Additionally, the companies operating in the market are mainly concentrating on strategic collaborations and mergers and acquisition, which is expected to support market growth. Asia-Pacific is estimated to be the fastest-growing market due to the increasing incidence of chronic diseases, the government encouragement in the healthcare sector, and growing the working population in the healthcare industry. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare facilities.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/automated-hospital-beds-market-4250

 

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com